SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-003224
Filing Date
2024-03-15
Accepted
2024-03-15 16:11:09
Documents
16
Period of Report
2024-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aimd_8k.htm   iXBRL 8-K 25529
  Complete submission text file 0001654954-24-003224.txt   164643

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aimd-20240313.xsd EX-101.SCH 6120
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimd-20240313_lab.xml EX-101.LAB 16245
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimd-20240313_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimd-20240313_pre.xml EX-101.PRE 11908
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimd-20240313_def.xml EX-101.DEF 4149
17 EXTRACTED XBRL INSTANCE DOCUMENT aimd_8k_htm.xml XML 5578
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41461 | Film No.: 24754847
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)